Biomarkers in Cancer

Similarity of Serum and Plasma Insulin-like Growth Factor Concentrations

Submit a Paper

Biomarkers in Cancer 2015:7 13-17

Short Report

Published on 08 Jun 2015

DOI: 10.4137/BIC.S23088

Further metadata provided in PDF

Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer


Background: Insulin-like growth factors (IGFs) are implicated in many normal physiological processes and pathological states, including cancer. For large consortia projects, it may be necessary to make comparisons among studies with different specimens that were not collected specifically to optimize the measurement of IGFs.

Objective: This study aimed to compare IGFs in matched serum and plasma samples.

Methods: We measured IGF-I, IGF-II, insulin-like growth factor-binding protein (IGFBP)-3, C-peptide, and leptin in serum and ethylenediaminetetraacetic–containing-plasma samples obtained concurrently from 30 healthy women aged 64–80 years in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial using chemiluminescent or colorimetric enzyme-linked immune assays. Coefficients of variation (CVs) and correlations were determined.

Results: Intraassay CVs ranged from 0.4% for IGFBP-3 to 10% for IGF-II. Mean concentrations of all analytes were higher in the serum, but the differences in mean concentrations of the analytes between serum and plasma were all <11%. Concordance correlation coefficients of matched serum/plasma specimens were 0.92, 0.91, 0.82, 0.96, and 0.99 for IGF-I, IGFBP-3, IGF-II, C-peptide, and leptin, respectively.

Conclusion: IGF concentrations measured in serum and plasma are highly correlated but are consistently slightly higher in serum, suggesting that IGF values should be corrected for systematic bias, particularly in consortial efforts when pooling data derived from different specimens.




BibTex citation   (BIBDESK, LATEX)


What Your Colleagues Say About Biomarkers in Cancer
I had a great experience in publishing a review article in Biomarkers in Cancer.  The submission process was extremely smooth and peer review was fast and channelized.  At each and every step I was able to monitor the progress.  Response to my communication was instant and every time confirmation emails were sent.  The publication processing team provided excellent support for proof reading and corrections.  I recommend publishing in it and wish them success. ...
Dr Ranjit Chauhan (University of Winnipeg, Winnipeg, MB, Canada)
More Testimonials

Quick Links

New article and journal news notification services